<?xml version="1.0" encoding="UTF-8"?>
<fn-group>
 <fn fn-type="financial-disclosure">
  <p>Dr. Tignanelli is a principal investigator for two randomized control trials investigating angiotensin-receptor blockers in the treatment of coronavirus disease 2019 among inpatient and outpatients. Co-investigators include Dr. Ingraham. Dr. Ingraham received funding from National Institutes of Health and National Heart, Lung, and Blood Institute (T32HL07741).</p>
 </fn>
</fn-group>
